| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 15, 2021Strong ESG practices result in inclusion on the Dow Jones Sustainability World Index
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced its inclusion in the Dow Jones® Sustainability World Index (DJSI World) as one of the world's leading companies...
-
Nov 9, 2021
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2022 on Tuesday, November 23, 2021....
-
Nov 4, 2021
New data from Medtronic Patient Preference study presented at TCT 2021; Medtronic adds to its clinical leadership for renal denervation with launch of the SPYRAL AFFIRM study DUBLIN and ORLANDO,...
-
Oct 12, 2021
Company to highlight environmental, social, and governance (ESG) efforts in inaugural ESG Investor Briefing DUBLIN, Oct. 12, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today released its fiscal...
-
Oct 4, 2021Study Published in JAMA Cardiology Demonstrates a Three-Fold Increased Risk of Ischemic Stroke Within 30 Days of a Multi-Hour AF Event
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the publication of a study demonstrating, through the use of a Medtronic continuous rhythm monitoring device,...
-
Sep 30, 2021Industry Leading Portfolio of Integrated Solutions Sets a New Standard for Minimally Invasive Spine Procedures, Beginning with MIS+ TLIF
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine...
-
Sep 28, 2021- Portfolio Features First Catheter Specifically Designed to Allow Neurointerventionalists Radial Artery Access, Delivers Advantages to Patients Treated for Stroke, Brain Aneurysms, Other Neurovascular Conditions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE Mark approval for its radial artery access portfolio, which includes the Rist™ 079 Radial...
-
Sep 7, 2021
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences: 2021 Virtual Wells Fargo Healthcare...
-
Sep 7, 2021
Results Demonstrate Feasibility of Bronchoscopic Microwave Ablation for Certain Patients with Malignant Lung Nodules DUBLIN, Sept. 7, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global...
Aug 24, 2021Strong Financial Performance on Continued Procedure Volume Recovery and Share Gains from New Product LaunchesMedtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2022, which ended July 30, 2021. Key Highlights Revenue of $8.0 Billion Increased 23% Reported and...
-
Aug 10, 2021
Medtronic plc (NYSE:MDT) announced today that it will report financial results for its first quarter of fiscal year 2022 on Tuesday, August 24, 2021. A news release will be issued at approximately...
-
Aug 6, 2021Acquisition to Add Innovative Bioabsorbable Drug Release Platform to Chronic Rhinosinusitis Portfolio
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has entered into a definitive agreement with Intersect ENT (NASDAQ: XENT), a global ear, nose, and throat...
-
Jul 28, 2021
AI Algorithms Enhance LINQ II™ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients DUBLIN, July 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global...
-
Jun 28, 2021
Data Were Presented at the American Diabetes Association 81st Scientific Sessions DUBLIN, June 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today...
-
Jun 23, 2021Data Showcases the Company's Most Advanced Product Portfolio Designed to Meet Patients Where They Are In Their Diabetes Journey
Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 81th scientific sessions virtual meeting, June...
-
Jun 21, 2021
- First and Only Approval to Indicate Cryoablation as an Initial Rhythm Control Strategy - Offers Safe, Effective Alternative to Antiarrhythmic Drug Therapy for the Prevention of Atrial Arrythmia...
-
Jun 7, 2021Publication in JAMA Shows Reveal LINQ™ ICM Demonstrated a Seven-Fold Increase in Detecting AF vs. Standard of Care
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal LINQ™ Insertable...
Jun 7, 2021The SenSight™ Directional Lead System Was Designed to Enable Precision, Personalization and Enhanced Patient ComfortMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. Food and Drug Administration (FDA) approval and first U.S. implants of the SenSight™ Directional Lead...
-
Jun 3, 2021
- Company Developing Support Program for Current HVAD Patients - Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021...
-
Jun 1, 2021
Data on the Company's Holistic Portfolio Will Include Real-World Data on MiniMed™ 780G System and New Data on Medtronic Continuous Glucose Monitoring Systems and Extended-Wear Infusion Set...
-
May 27, 2021- Q4 Revenue of $8.2 Billion Increased 37% Reported and 32% Organic
Medtronic plc (NYSE:MDT) today announced financial results for its fourth quarter and fiscal year 2021, which ended April 30, 2021. The company reported fourth quarter worldwide revenue of $8.188...
-
May 25, 2021
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences: Jefferies Virtual Healthcare Conference
-
May 18, 2021EuroPCR: Low Risk Study Demonstrates Hemodynamic Advantages of Evolut™ Transcatheter Aortic Valve Replacement (TAVR) System Over Open Heart Surgery Out to Two Years
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the complete two-year outcomes from the landmark Evolut Low Risk Trial comparing the minimally invasive Evolut™...
-
May 18, 2021
Medtronic Launches New GSR-DEFINE Study to Expand Real-World Data to 5,000 Patients DUBLIN, May 18, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today...
-
May 13, 2021
Medtronic plc (NYSE:MDT) announced today that it will report financial results for its fourth quarter and full fiscal year 2021 on Thursday, May 27, 2021. A news release will be issued at...
May 10, 2021SonarMed™ Airway Monitoring System Continuously Checks for Endotracheal Tube Obstruction and Position for Neonates and Infants Providing Immediate, Actionable Intelligence for CliniciansMedtronic plc (NYSE:MDT), the global leader in medical technology, today announced the U.S. commercial launch of the SonarMed™ airway monitoring system. The first and only device of its kind,...
Apr 12, 2021- The GI Genius™ Module Assists Physicians in Detecting Pre-Cancerous Growths; Potentially Addressing 19 Million Colonoscopies Annually - Transformative AI Colorectal Cancer Prevention Platform...
-
Mar 31, 2021Value-Based Healthcare Programs Will Be Designed to Improve Patient Outcomes, Reduce Cost of Care
Spectrum Health and Medtronic plc (NYSE:MDT) have entered into an agreement with the goal of driving value in healthcare and improving outcomes for Spectrum Health patients, while reducing the...
-
Mar 4, 2021
Study Will Determine the Safety and Effectiveness of Pulsed Electrical Fields to Interrupt Irregular Heart Rhythms DUBLIN, March 4, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global...
-
Feb 23, 2021
- Q3 Revenue of $7.8 Billion Increased 0.8% as Reported and Decreased 1.0% Organically - Q3 GAAP Diluted EPS of $0.94; Q3 Non-GAAP Diluted EPS of $1.29 DUBLIN, Feb. 23, 2021 /PRNewswire/ --...
-
Feb 17, 2021
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the following upcoming investor conferences, with its executives answering...
-
Feb 17, 2021
Medtronic plc (NYSE:MDT), the global leader in medical technology, has voluntarily issued a global recall of unused Medtronic Valiant Navion™ thoracic stent graft system and informed physicians...
-
Feb 16, 2021
Medtronic plc (NYSE:MDT) announced today that it will report financial results for its third quarter of fiscal year 2021 on Tuesday, February 23, 2021. A news release will be issued at...
-
Jan 4, 2021
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021....
-
Dec 1, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Evercore ISI 3rd Annual HealthCONx Conference on Thursday, December 3, 2020....
-
Nov 30, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Piper Sandler 32nd Annual Healthcare Conference on Wednesday, December 2,...
-
Nov 24, 2020
- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc...
-
Nov 17, 2020
Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter of fiscal year 2021 on Tuesday, November 24, 2020. A news release will be issued at...
-
Nov 16, 2020Results from Three Studies Show Medtronic Cryoablation is Superior to Drug Therapy for First-Line Treatment
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the primary results of the Medtronic-sponsored STOP AF First clinical trial have been published in the New...
-
Oct 26, 2020Abre™ Venous Self-Expanding Stent System Safe, Effective in Treating Challenging Deep Venous Lesions
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval for the Abre™ venous self-expanding stent...
-
Oct 14, 2020
Company Raises Revenue Growth Outlook Highlights Deep and Broad Pipeline and Technology Platforms DUBLIN, Oct. 14, 2020 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical...
-
Oct 5, 2020
Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Event on Wednesday, October 14, 2020, from 8:00 a.m. to approximately 2:00 p.m....
-
Sep 29, 2020
Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ("Medtronic Luxco") has closed a registered public offering (the...
-
Sep 24, 2020
Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering (the "Offering") of...
-
Sep 23, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced first enrollments in the ALLEVIATE-HF clinical trial which will evaluate the ability of its Reveal LINQ™...
-
Sep 11, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate virtually in the Morgan Stanley 18th Annual Global Healthcare Conference on Monday, September...
-
Sep 10, 2020PRODIGY Study Provides First Validated Risk Prediction Tool to Guide Continuous Monitoring for Opioid-Induced Respiratory Depression (OIRD)
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the publication of primary data from PRODIGY (PRediction of Opioid-induced respiratory Depression In patients...
-
Sep 4, 2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Wells Fargo Securities 2020 Virtual Healthcare Conference on Thursday, September 10, 2020.
-
Sep 1, 2020New Smartphone Connected Hybrid Closed Loop System Will Be Available to Individuals as Young as 2
DUBLIN – September 1, 2020 – Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) approval of its...
-
Aug 29, 2020ESC Congress: New Research Highlights First-Line Use of Cryoablation as Highly Effective, and with Improved Quality of Life Scores
DUBLIN, Aug. 29, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced clinical trial results demonstrating superiority of the Arctic Front™...